Research publications

Alfred Health research outcomes are published in a wide range of peer reviewed journals. 

Search or browse research publications by year, research area, publication type or keyword.

Clear filter
Publication Details
Current modalities for invasive and non-invasive monitoring of volume status in heart failure

von Lueder TG, Krum H

(2012), Heart, 98(13), 967-73

Antagonists of organic anion transporters 1 and 3 ameliorate adverse cardiac remodelling induced by uremic toxin indoxyl sulfate

Liu S, Wang BH, Kompa AR, Lekawanvijit S, Krum H

(2012), Int J Cardiol, 158(3), 457-8

FT011, a new anti-fibrotic drug, attenuates fibrosis and chronic heart failure in experimental diabetic cardiomyopathy

Zhang Y, Edgley AJ, Cox AJ, Powell AK, Wang B, Kompa AR, Stapleton DI, Zammit SC, Williams SJ, Krum H, Gilbert RE, Kelly DJ

(2012), Eur J Heart Fail, 14(5), 549-62

Eplerenone for the treatment of cardiovascular disorders

Watanabe M, Krum H

(2012), Expert Rev Cardiovasc Ther, 10(7), 831-8

Peptidomic profiles of post myocardial infarction rats affinity depleted plasma using matrix-assisted laser desorption/ionization time of flight (MALDI-ToF) mass spectrometry

Wang BH, Reisman S, Bailey M, Kompa A, Ayhan M, Krum H, Rice G

(2012), Clin Transl Med, 1(1), 11

FT23, an orally active antifibrotic compound, attenuates structural and functional abnormalities in an experimental model of diabetic cardiomyopathy

Tan SM, Zhang Y, Wang B, Tan CY, Zammit SC, Williams SJ, Krum H, Kelly DJ

(2012), Clin Exp Pharmacol Physiol, 39(8), 650-6

Clinical service organisation for heart failure

Takeda A, Taylor SJ, Taylor RS, Khan F, Krum H, Underwood M

(2012), Cochrane Database Syst Rev, 9, CD002752

Eplerenone and atrial fibrillation in mild systolic heart failure: results from the EMPHASIS-HF (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure) study

Swedberg K, Zannad F, McMurray JJ, Krum H, van Veldhuisen DJ, Shi H, Vincent J, Pitt B; EMPHASIS-HF Study Investigators

(2012), J Am Coll Cardiol, 59(18), 1598-603

International variation in use of oral anticoagulation among heart failure patients with atrial fibrillation

Suarez J, Piccini JP, Liang L, Atherton JJ, Hayward CS, Krum H, Fonarow GC, Lopes RD, Hernandez AF

(2012), Am Heart J, 163(5), 804-11

Effect of intensive structured care on individual blood pressure targets in primary care: multicentre randomised controlled trial

Stewart S, Carrington MJ, Swemmer CH, Anderson C, Kurstjens NP, Amerena J, Brown A, Burrell LM, de Looze FJ, Harris M, Hung J, Krum H, Nelson M, Schlaich M, Stocks NP, Jennings GL; VIPER-BP Study Investigators

(2012), Br Med J, 345, e7156

Impact of home versus clinic-based management of chronic heart failure: the WHICH? (Which Heart Failure Intervention Is Most Cost-Effective & Consumer Friendly in Reducing Hospital Care) multicenter, randomized trial

Stewart S, Carrington MJ, Marwick TH, Davidson PM, Macdonald P, Horowitz JD, Krum H, Newton PJ, Reid C, Chan YK, Scuffham PA

(2012), J Am Coll Cardiol, 60(14), 1239-48

The role of renal denervation in the treatment of heart failure

Sobotka PA, Krum H, Böhm M, Francis DP, Schlaich MP

(2012), Curr Cardiol Rep, 14(3), 285-92

Effects of renal denervation on sympathetic activation, blood pressure, and glucose metabolism in patients with resistant hypertension

Schlaich MP, Hering D, Sobotka P, Krum H, Lambert GW, Lambert E, Esler MD

(2012), Front Physiol, 3, 10

Renal denervation in human hypertension: mechanisms, current findings, and future prospects

Schlaich MP, Hering D, Sobotka PA, Krum H, Esler MD

(2012), Curr Hypertens Rep, 14(3), 247-53

Eplerenone in patients with systolic heart failure and mild symptoms: analysis of repeat hospitalizations

Rogers JK, McMurray JJ, Pocock SJ, Zannad F, Krum H, van Veldhuisen DJ, Swedberg K, Shi H, Vincent J, Pitt B

(2012), Circulation, 126(19), 2317-23

Eplerenone and new-onset diabetes in patients with mild heart failure: results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF)

Preiss D, van Veldhuisen DJ, Sattar N, Krum H, Swedberg K, Shi H, Vincent J, Pocock SJ, Pitt B, Zannad F, McMurray JJ

(2012), Eur J Heart Fail, 14(8), 909-15

Rationale and design of ARTS: a randomized, double-blind study of BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease

Pitt B, Filippatos G, Gheorghiade M, Kober L, Krum H, Ponikowski P, Nowack C, Kolkhof P, Kim SY, Zannad F

(2012), Eur J Heart Fail, 14(6), 668-75

Palliative care for patients with chronic obstructive pulmonary disease: exploring the landscape

Philip J, Lowe A, Gold M, Brand C, Miller B, Douglass J, Sundararajan V

(2012), Intern Med J, 42(9), 1053-57

Negotiating hope with chronic obstructive pulmonary disease patients: a qualitative study of patients and healthcare professionals

Philip J, Gold M, Brand C, Douglass J, Miller B, Sundararajan V

(2012), Intern Med J, 42(7), 816-22

The acute haemodynamic effect of nebulised frusemide in stable, advanced heart failure

Newton PJ, Davidson PM, Krum H, Ollerton R, Macdonald P

(2012), Heart Lung Circ, 21(5), 260-6

581 582 583 584 585